BLRX
BioLineRx Ltd. - American Depositary Shares (BLRX)
$54
About BioLineRx Ltd. - American Depositary Shares (BLRX)
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.
Details
Daily high
$2.54
Daily low
$2.45
Price at open
$2.45
52 Week High
$4.56
52 Week Low
$2.15
Market cap
12.1M
Dividend yield
-
Volume
2,350
Avg. volume
29,146
P/E ratio
-1.37
BioLineRx Ltd. - American Depositary Shares News
Details
Daily high
$2.54
Daily low
$2.45
Price at open
$2.45
52 Week High
$4.56
52 Week Low
$2.15
Market cap
12.1M
Dividend yield
-
Volume
2,350
Avg. volume
29,146
P/E ratio
-1.37